Children with HIV/AIDS are up to 40 times more likely to contract pneumococcal disease than children without HIV/AIDS.

Children with HIV/AIDS are up to 40 times more likely to contract pneumococcal disease than children without HIV/AIDS.

Press Releases

Read the latest PneumoADIP press releases on research, exciting announcements and the progress of the global community in accelerating access to pneumococcal vaccines for the world’s most vulnerable children.

10 JUNE 2008

Health Experts Call on Global Leaders to Ensure Access to Life-Saving Pneumococcal Vaccines.
Read more >>

28 NOVEMBER 2007:

Pneumococcal Conjugate Vaccines Can Improve the Lives of HIV-Infected Children.
Read more >>

29 MARCH 2007:

Thai Ministry of Public Health and WHO Host Meeting of Leading Researchers to Highlight Burden of Meningitis and Pneumonia.
Read more >>

23 MARCH 2007:

Routine Use of Pneumococcal Conjugate Vaccine in the Developing World Considered Priority by WHO to Help Save Millions of Lives.
Read more >>

9 FEBRUARY 2007:

$US1.5 Billion donor commitment launches pilot Advance Market Commitment for pneumococcal vaccines.
Read more >>

29 NOVEMBER 2006:

GAVI Alliance announces important step in preventing childhood deaths from pneumococcal diseases.
Read more >>

18 SEPTEMBER 2006:

UNICEF and WHO launch a major report about the global health problem of childhood pneumonia. Preventing deaths from pneumonia is essential if developing countries are to meet child survival targets.
Read more >>

07 SEPTEMBER 2006:

Immunizations Groups Welcome Meeting to Discuss Advance Market Commitment for New Vaccines.
Read more >>

18 MAY 2006:

Leading Experts Urge Commitment from Industry and International Donors to Prepare for the Introduction of Pneumococcal Vaccines.
Read more >>

5 APRIL 2006:

New Global Task Force to Implement Pneumonia Call to Action by 2008.
Read more >>

4 APRIL 2006:

PneumoADIP Hails New Funding for Vaccine Development.
Read more >>

15 FEBRUARY 2006:

WHO Meeting Brings Together Leading Experts to Discuss Burden of Pneumococcal Disease.
Read more >>

25 MARCH 2005:

The Gambia study is the first trial in 20 years to show significant reduction in child mortality.
Gambia Press Release >>
The Human Face of Pneumococcal Disease in Africa >>
Background about The Gambia Pneumococcal Vaccine Trial >>
Background about Pneumococcal Disease >>

18 JANUARY 2005:

Leading Experts Unite to Understand the Burden of Pneumococcal Disease.
Read more >>

21 SEPTEMBER 2004:

Researchers and Policy Makers Told to “Fast Track” Access to Childhood Vaccines Suited for the Developing World.
Read more >>

30 MAY 2004:

PneumoADIP calls for Letters of Interest from Potential Asian and Pacific Vaccine Evaluation Sites.
Read more >>

10 MAY 2004:

Up to One Million Child Deaths are Preventable.
Read more >>

15 APRIL 2004:

New Opportunity for Pneumococcal Research in Developing Countries.
Read more >>

The Pneumococcal vaccines Accelerated Development and Introduction Plan is based
at Johns Hopkins Bloomberg School of Public Health and is funded by GAVI Alliance.